Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury
Recent studies on liver disease burden worldwide estimated that cirrhosis is the 11th most common cause of death globally, and there is a great need for new therapies to limit the progression of liver injuries in the early stages. Cholestasis is caused by accumulation of hydrophobic bile acids (BA)...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI AG
2021-07-01
|
| Colección: | Cells |
| Materias: | |
| Acceso en línea: | https://www.mdpi.com/2073-4409/10/8/1846 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|